Method of inhibiting carcinogenesis by treatment with dehydroepiandrosterone and analogs thereof
US5527789A · kind A · utility
30Cited by
2References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 2, 1994 |
| Grant date | Jun 18, 1996 |
| Priority date | — |
| Expiry date | Aug 2, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of combatting cancer in a subject comprising administering to said subject dehydroepiandrosterone (DHEA) or an analog thereof in an amount effective to combat cancer is disclosed in which heart failure induced by the DHEA or analog thereof is combatted by administering to the subject a ubiquinone, in an amount effective to combat heart failure induced by the DHEA or analog thereof. A prefered DHEA analog for carrying out the invention is 16 alpha-fluoroepiandrosterone, and a preferred ubiquinone for carrying out the invention is Coenzyme Q.sub.10.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.